METHODS: A systematic review was performed using the Ovid (Medline/PubMed) database, in accordance with the PRISMA checklist.
RESULTS: In total 7 articles were included within this systematic review. A total of 652 patients were included. Liposuction-only breast reduction appears to lead to improvements in subjective outcome measures, patient satisfaction, and objective outcomes such as moderate breast volume reduction and reduction in breast ptosis. Overall, the procedure had a low complication profile. Liposuction did not preclude further surgery. No evidence of malignancy or difficulty in future breast cancer screening was noted.
CONCLUSIONS: Macromastia leads to a considerable health burden, especially in health-related costs. From the current evidence base, liposuction-only breast reduction appears to be a safe and effective procedure, especially in patients requiring a mild-moderate breast volume reduction and mild ptosis correction. More research is required, with standardised subjective and objective outcome measures, and longer follow-up periods to confirm the effectiveness and safety of this technique. Level of Evidence III This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine Ratings, please refer to Table of Contents or online Instructions to Authors www.springer.com/00266 .
方法:使用Ovid(Medline/PubMed)数据库进行了系统评价,根据PRISMA清单。
结果:本系统综述共纳入7篇文章。共纳入652例患者。仅吸脂乳房减少似乎可以改善主观结果指标,患者满意度,和客观的结果,如适度的乳房体积减少和乳房下垂减少。总的来说,该手术的并发症发生率较低.吸脂术并不排除进一步的手术。没有发现恶性肿瘤或未来乳腺癌筛查困难的证据。
结论:巨灾导致相当大的健康负担,特别是与健康相关的费用。从目前的证据基础来看,仅吸脂乳房缩小似乎是一种安全有效的手术,特别是在需要轻度-中度乳房体积缩小和轻度下垂矫正的患者中。需要更多的研究,采用标准化的主观和客观结果衡量标准,和更长的随访时间,以确认该技术的有效性和安全性。证据级别III本期刊要求作者为每篇文章分配一个级别的证据。对于这些循证医学评级的完整描述,请参阅目录或在线作者说明www。springer.com/00266.